Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary aim of this study is to to retrospectively evaluate the efficacy of the MWCC Jump Start (Medifast's 5 & 1) Plan on the following indices: weight loss, anthropometric changes, and reduction in common markers of coronary heart disease.
Portion-controlled meal replacements by themselves have been shown to be an effective weight control strategy in overweight and obese individuals. The addition of medical supervision has been shown to result in greater weight loss than meal replacements alone. MWCC provides this added support through individual weekly counseling sessions. Thus, the investigators plan to retrospectively evaluate the efficacy of the MWCC Jump Start (Medifast's 5 & 1) Plan on the following indices: weight loss, anthropometric changes, and reduction in common markers of coronary heart disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MWCC clients | This study will be a systematic retrospective chart review of clients participating in the Jump Start (5 & 1) Plan at three different MWCC locations in Texas during the years 2007 - 2010. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Changes in weight | Weight loss (in pounds and percent weight loss) at weeks 4, 12, 24 and at final weight loss visit (average of 19.6 weeks). | weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks) |
| Changes in body composition | changes in lean muscle mass, body fat mass, and body fat percent at weeks 4, 12, 24, and final weight loss visit(average of 19.6 weeks). | weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| Compliance | Compliance is measured by client attendance at weekly visits, consumption of meal replacements and dietary supplements, ketone testing, and completion of food journals | weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks) |
| Retention rates |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
This study was a systematic retrospective chart review of patients participating in the Jump Start (5 & 1) Plan at three different MWCC locations in Texas during the years 2007-2010.
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 12704397 | Background | Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord. 2003 May;27(5):537-49. doi: 10.1038/sj.ijo.0802258. | |
| 18612258 | Background | Haddock CK, Poston WS, Foreyt JP, DiBartolomeo JJ, Warner PO. Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation. Eat Weight Disord. 2008 Jun;13(2):95-101. doi: 10.1007/BF03327609. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Retention of clients at specified time points (weeks 4, 12, 24 and final weight loss visit) and during the transition and weight maintenance phases of the MWCC weight management program |
| weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks) |
| Goal weight achievement | The percent of clients that achieve thier goal weight by their final weight loss visit(average of 19.6 weeks) | Final weight loss visit (average of 19.6 weeks) |
| Changes in abdominal circumference (inches) | weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks) |
| Maintenance of weight loss | Following transition (up to 12 weeks) and maintenance (up to 52 weeks) phases of the program |
| Changes in cardiovascular risk factors | Improvements in diastolic and systolic blood pressure and pulse at weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks). | weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks) |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |